Supriya Adak Email

Project Manager . ImmunoACT

Current Roles

Employees:
147
Revenue:
$0
About
Spun-out from IIT-Bombay in 2018, ImmunoACT is India's pioneer of Gene-modified Cell Therapies, having launched the country's first CAR-T cell therapy for treatment of certain B-cell malignancies. With a rapidly expanding pipeline beginning, our mission is to provide affordable access to novel CAR-T cell therapies.
ImmunoACT Address

Navi Mumbai, null
in
ImmunoACT Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.